Vasodilators during cerebral aneurysm surgery

16 Pages·2008·1.68 MB·English

775
Review Article
Vasodilators during
cerebral aneurysm
yregrus
Kazuo Abe DM
The objective of this review is to review the anaesthetic im- the drugs of choice for induced hypotension. Prostaglandin E t,
plications of vasoactive compounds particularly with regard to nicardipine and nitroglycerin have the advantage that they do
the cerebral circulation and their clinical importance for the not alter carbon dioxide reactivity. Local cerebral blood flow
practicing anaesthetist. Material was selected on the basis of is increased with nitroglycerin, decreased with trimetaphan and
validity and application to clinical practice and animal studies unchanged with prostaglandin E~ Intraoperative hypertension
were selected only if human studies were lacking. Hypotensive is a dangerous complication occurring during cerebral aneu-
drugs have been used to induce hypotension and in the treat- rysm surgery, but its treatment in association with subarachnoid
ment of intraoperative hypertension during cerebral aneurysm haemorrhage is complicated in cases of cerebral arterial va-
surgery. After subarachnoid haemorrhage, cerebral blood flow sospasm because fluctuations in cerebral blood flow may be
is reduced and cerebral vasoreactivity is disturbed which may exacerbated. Hypertension should be treated immediately to re-
lead to brain ischaemia. Also, cerebral arterial vasospasm de- duce the risk of rebleeding and intraoperative aneurysmal rup-
creases cerebral blood flow, and may lead to delayed ischaemic ture and the choice of drugs is discussed. Although the use
brain damage which is a major problem after subarachnoid of induced hypotension has declined, the control of arterial
haemorrhage. Recently, the use of induced hypotension has de- blood pressure with vasoactive drugs to reduce the risk of in-
creased although it is still useful in patients with intraoperative traoperative cerebral aneurysm rupture is a useful technique.
aneurysm rupture, giant cerebral aneurysm, fragile aneurysms Intraoperative hypertension should be treated immediately but
and multiple cerebral aneurysms. In this review, a variety of the cerebral vascular effects of each vasodilator shouM be un-
vasodilating agents, prostaglandin E ,I sodium nitroprusside, ni- derstood before their use as hypotensive agents.
troglycerin, trimetaphan, adenosine, calcium antagonists, and
inhalational anaesthetics, are discussed for their clinical use- L'objectif de cet article est de revoir les implications anesth$-
fulness. Sodium nitroprusside, nitroglycerin and isoflurane are siques des compos~s vasoactifs particuli~rement en rapport avec
la circulation cdr$brale ainsi que leur importance clinique pour
l'anesth~siste. Les agents ont ~t~ choisis sur la base de leur
yeK sdrow
validit~ et de leur application it la pratique clinique et des ~tudes
,SCITEHTSEANA :SELITALOV isoflurane;
animales ont dt~ choisies seulement en l'absence d~tude sur
CITEHTSEANA ;SEUQINHCET hypotension;
.emmo~71 Les agents hypotenseurs ont ~td utilis~s pour induire
DOOLB "ERUSSERP hypotension;
de 1 ~ypotension et pour traiter noisnetrepy~71 preop~ratoire pen-
:NIARB blood flow, carbon dioxide tension;
dant la chirurgie d'andvrisme c&~brale. Apr~s une hdmorragie
:SENOMROH prostaglandin El
sous-arachnoMienne, le d~bit sanguin cdr$brale r$duit et la va-
CITEHTAPMYS SUOVREN :METSYS ganglionic blockade,
somotriciM c&~brale perturb~e peuvent entrafner une isch~mie
trimetaphan;
.elarb$r~c Ainsi, le vasospasme artdriel cdrdbral diminue le d~bit
;YGOLOCAMRAHP adenosine, nitroglycerin, nitroprusside,
sanguin cdr~bral et peut conduire it des dommages c&~braux
calcium channel blockers, hydralazine, diazoxide,
retardes d'isch~mie, problbme majeur aprbs une h~morragie
labetalol, esmolol;
sous-arachnoMienne. R~cemment, I'utilisation de noisnetopy171
"SNOITACILPMOC intraoperafive hypertension, brain
contr61~e s'est rar~fi~e bien qu'elle soit encore utile chez les
ischaemia, rebleeding.
patients avec une rupture peropdratoire d'an~vrisme, en cos
From the Department of Anaesthesia, Osaka Police Hospital. d'an~vrisme c&$bral g~ant, d'an~vrismes fragiles et d'an-
Address correspondence to: Dr.Kazuo Abe, Department of ~vrismes cdr~braux multiples. Dans cet article, une varidtd de
Anaesthesia, Osaka Police Hospital, 10-31 Kitayama, Tennouji, vasodilatateurs, le prostaglandine E l, le nitroprussiate de so-
Osaka 543, Japan. dium, la nitroglycdrine, le trimdtaphan, l'ad~nosine, les anta-
Accepted for publication 17th April, .3991 gonistes calciques et les agents d'inhalation son discut~s pour
NAC J ANAESTH 3991 / :04 8 / pp 09-577
677 NAIDANAC LANRUOJ FO AISEHTSEANA
leur utilit~ cfinique. Le nitroprussiate de sodium, la nitrogly- velop abnormal cerebrovascular reactivity and impaired
cerine et l'isoflurane sont les agents de choix pour l~ypotension autoregulation 3,2 and they may be more susceptible to
contrrlke. La prostaglandine E t, la nicardipine et la nitrogly- severe flow reductions during hypotension than normal
cerine ont ravantage de ne pas alt~rer la ~tivitcaOr au dioxyde individuals, 4 resulting in global and or focal ischaemia
de carbone. Le d~bit sanguin c~r~bral local est augment~ avec of the brain. 5 During the first two weeks after SAH,
la nitroglycerine, diminu~ avec le trim~taphan et inchang~ avec several events may make heavy demands on the capacity
la prostaglandine E .I L'hypertension perop~ratoire est une com- of the cerebral vasculature to react adequately. Cerebral
plication dangereuse aux cours d'une chirurgie d'an~vrisme arterial vasospasm and rebleeding are major problems
,larb~rOc mais son traitement lors d'hdmorragie sous- and cerebral aneurysm surgery is often performed within
arachnoMienne se complique dans les cas de vasospasme ar- the same period. Another problem during general anaes-
t~riel c~r~bral parce que les fluctuations du d~bit sanguin thesia for aneurysm clipping is intraoperative hyperten-
larb~r~c peuvent s'exacerber. L'hypertension devrait 6tre traitke sion. Intraoperative hypertension may increase the risk
imm~diatement pour r~duire le risque de resaignement et de of rebleeding and intraoperative aneurysm rupture before
rupture perop~ratoire de l'anOvrisme. Le choix des agents est its exposure so that intraoperative blood pressure should
discut~. Bien que l'utilisation de l'hypotension contrOl~e est be well controlled.
moins fr~quente, le contrrle de la pression art~rielle avec des
agents vasoactifs dans le but de r~duire le risque de rupture Pathophysiology
perop~ratoire d'anOvrisme c~r~bral est une technique courante.
L'hypertension perop~ratoire devrait ~tre traitOe imm~diatement Subarachnoid haemorrhage
mais les effets vasculaires c~rObraux de chaque vasodilatateurs Ten percent of all strokes result from subarachnoid haem-
devraient 6tre compris avant qu'ils soient utilis~s comme agents orrhage (SAH) which si caused most often by the sudden
hypotenseurs. rupture of an intracranial saccular aneurysm. Subarach-
noid haemorrhage chiefly afflicts patients between 40 and
60 yr of age and women are affected more often than
Contents men. Rupture of an intracranial arterial aneurysm pro-
Introduction
duces severe focal and generalized disturbances in brain
Pathophysiology
function (Figure .)1 Depending on the surgical risk, pa-
Subarachnoid haemorrhage
-
tients may present a broad spectrum of clinical conditions,
- Cerebral vasospasm
ranging from non-ruptured aneurysm (grade 0) to deep
Cerebral haemodynamics
coma (Grade V). 6 Delayed cerebral ischaemia is the
- Carbon dioxide reactivity
major cause of poor outcome or death after SAH. The
- Autoregulation
risk of delayed ischaemia and cerebral infarction after
- Cerebral blood flow
SAH is dependent on many factors, the most important
- Cerebral arterial blood flow velocity
of which are the amount of blood in the basal cisterns,
Induced hypotension
the presence of intracranial haematoma and the patient's
Hypotensive drugs
clinical condition. 7 Subarachnoid haemorrhage from rup-
Prostaglandin El
- ture of an intracranial arterial aneurysm produces severe
- Sodium nitroprusside
focal and generalized disturbances in brain function. Rup-
Adenosine
- ture of a cerebral aneurysm with subsequent arterial
- Nitroglycerin
bleeding may cause dramatic changes in intracranial pres-
- Trimetaphan
sure (ICP) 8 (Figure 2). In severe haemorrhage, cerebral
- Calcium channel blockers
perfusion pressure may decrease to low levels with a con-
Isoflurane
- comitant decrease in cerebral blood flow. Severely
ele-
- Other vasodilators
ICP may also lead to brain herniation. Following
vated
Clinical implications
SAH, dilated ventricles can be seen with computerized
tomographic (CT) and scanning at admission can be used
During the clipping of cerebral arterial aneurysms, in- to classify the severity of haematoma. Computerized to-
duced hypotension is often used to reduce the aneurysmal mographic scanning is valuable in identifying the patient's
wall tension to minimize risk of premature rupture, l risk of brain ischaemia after SAH. 9
the
A primary concern with the use of hypotension has been Brain damage may be caused by a marked increase
that cerebral blood flow (CBF) may decrease to critically in intracranial pressure and mechanical distortion of in-
low levels, resulting in ischaemic damage to the brain. tracranial structures resulting from the sudden injection
Patients with subarachnoid haemorrhage (SAH) may of blood into the subarachnoid space. 01 Some patients
de-
:ebA NOISNETOPYH DNA HAS 777
et al. s~ performed 101 quantitative bedside CBF meas-
urements on 40 patients to correlate the severity of SAH
with CBE In patients with low-grade SAH, global CBF
was within normal limits before and after surgery but
increased for two weeks postoperatively, while in the pa-
tients with high-grade SAH there was no increase in CBF
one week after surgery. Voldby et af. reported that the
cerebral metabolic rate of oxygen (CMROz) was more
severely reduced than regional CBF during the first two
weeks after SAH. 71 The most marked depressions of
CMRO2 and regional CBF were seen with the devel-
opment of focal neurological deficits. 7~,41
The complications associated with SAH are complex
and include cerebral oedema, increased ICP, diffuse cere-
bral ischaemia, rebleeding, cerebral arterial vasospasm
and hydrocephalus. The presence of oedema, hydroce-
phalus, and intracranial hypertension following SAI-I may
cause regional CBF and cerebral metabofism to dete-
riorate even further. 9~,8~ Neurological status after SAH
is evaluated by the classification of Hunt and Hess ~2
ERUGIF ! Giant larberec msyruena (~) gnitanigiro morf lanretni (Table I). The Glasgow Outcome Scale t2 si often used
ditorac yretra laretal( )weiv ni a dlo-ry-56 .namow
to determine the outcome of patients with head trauma.
In general, the probability of survival for each of the
grades of the Hunt and Hess system increases with the
interval between the initial haemorrhagc and the time
that the clinical grade si determined, 2z For example a
patient graded I on the first day after the SAH has a
65% chance of survival, whereas a similar grading 12
days later indicates a 95% chance of surviving. 32 The
operative results from delayed surgery are not superior
to those of early surgery. Ljunggren et aL 42 studying 912
patients, reported good recovery in 76% of patients un-
dergoing late surgery (more than eight days after SAH)
and in 74% of patients undergoing early surgery group
(within 2.5 days of SAH). All patients were grade I-III
(Hunt and Hess classification). The Cooperative Aneu-
ERUGIF 2 ralucirtnevartnI erusserp gnirud tnerrucer egahrromeah
ni dlo-ry-75 nam htiw roiretna gnitacinummoc yretra .msyruena morf( rysm Study, performed in 3521 aneurysm patients in 68
Votdby B. snoitaretlA ni rotomosav ytivitcaer ni dionhcarabus neurosurgical centres, showed that the incidence of re-
.egahrromeh In: dooW JH (Ed,). r._C doolb .wolf lliH-warGcM bleeding in patients operated upon within the first three
kooB ynapmoC ;7891 ).404
days after SAH was lower (6%) than in patients operated
upon 7 to 11 days after SAH (14%). 52 Although there
have symptoms consistent with hydrocephalus. ~; The was a reduction in the rebleeding rate after early surgery,
most predictable factors for the development of hydroce- the timing of operation did not influence the overall mor-
phalus are age, hypertension, CT findings of hydroce- bidity and mortality. However, in the North American
phalus, and intraventricular haemorrhage. In order to Subset of the International Cooperative Study, the best
reduce ICP and to reduce the risk of brain herniation, results were obtained when surgery was performed within
cerebrospinal drainage can be considered, but this is con- three days of SAH. 62 From 1980 through 1983, 277
troversial. 21 Subarachnoid haemorrhage causes a consid- (21.9% of total 3521 patients) patients admitted to 27
erable decrease in both CBF and metabolism. sJ-3~ The neurosurgical centers in the United States and Canada
reduction in regional CBF and metabolism may oeeur from days 0 to 3 after SAH were enrolled in the study.
even in patients in good clinical condition and without Overall outcome in patients planned for surgery on days
vasospasm. Patients in poorer clinical condition have 0-3 after SAH was equivalent in terms of mortality to
more marked reduction of CBF and metabolism. Mountz patients planned for surgery on days 11-32 after SAH,
877 CANADIAN JOURNAL OF ANAESTHESIA
TABLE I Neurological grading system for patients with SAH
Grade Criteria
Grade 1 Asymptomatic or minimal headache and slight nuchal rigidity
Grade It Moderate to severe headache, nuchal rigidity, no neurologic deficit other than cranial nerve palsy
Grade 111 Drowsiness, confusion, or mild focal deficit
Grade IV Stupor, moderate to severe hemiparesis
Grade V Deep coma, decerebrate rigidity, moribund appearance
From Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial
aneurysms. J Neurosurg 1968; 28: .41
but early surgery showed improved recovery. Patients categories: )1( prevention or reversal of the arterial nar-
planned for surgery 7-10 days after SAH had nearly rowing, )2( prevention or reversal of the ischaemic neu-
twice the mortality of other intervals. These results argue rological deficits, and )3( protection from infarction. 82 Di-
for early diagnosis and surgical intervention after SAH. rect pharmacological dilatation of spastic vessels has not
been demonstrated but therapy may be directed to prevent
Cerebral vasospasm its development or ameliorate the ischaemic consequen-
In the past, rebleeding was considered to be one of the ces. 34-36 Several agents have been used to prevent or re-
major causes of morbidity and mortality of SAH. Of verse the arterial narrowing. Calcium channel blocking
2265 patients admitted to the Cooperative Aneurysm agents have been used because the contraction of cerebral
Study, Kassell et al. reported that 4.1% of patients rebled arterial smooth muscle cells is calcium-dependent and
during the first 24 hr after the initial haemorrhage. Re- can be blocked by preventing the influx of extracellular
bleeding was documented by bloody spinal fluid or CT calcium. Nimodipine has proved effective both in reduc-
scanning. They concluded that rebleeding occurred most ing the mortality rate and in diminishing the severity and
commonly during the first 24 hr with a cumulative rate incidence of permanent deficits caused by delayed ischae-
of approximately 20% during the first two weeks after mic deterioration. 83-63.43
the initial SAH. 72 Recently, Kassell et al. 82 demonstrated
that cerebral vasospasm following aneurysmal SAH was larbereC scimanydomeah
one of the most important causes of cerebral ischaemia
and was the main cause of death and disability in patients Carbon dioxide reactivity
with SAH. Vasospasm, especially of the severe and dif- Cerebral arteries and arterioles react quickly to changes
fuse variety, was associated with a reduction in both re- in PaCO2. In the PaCO 2 range 52 to 60 mmHg the re-
gional CBF and 71,41.2ORMC cihpargoignm vasospasm lationship between CBF and PaCO2 is linear, with a flow
is defined as a narrowing of the column of dye in the change of about 4% per millimeter of mercury. 93 The
major cerebral arteries. The narrowing is time-dependent, vascular reactivity to carbon dioxide is considered to be
rarely pronounced before the fourth day after the initial the predominant factor in the regulation of regional CBF
haemorrhage and reaches a peak at about the seventh and seems to be a stable phenomenon. Even after severe
day. 13-92 Clinical cerebral vasospasm, the syndrome of head trauma or stroke, carbon dioxide reactivity is at
the ischaemic consequences of cerebral artery narrowing, least partially preserved, ~4 but Schaltn et al. reported
is characterized by an insidious onset of confusion and that loss of carbon dioxide reactivity is a good predictor
decreased level of consciousness followed by focal motor of outcome from head injury. 24 Reduction of cerebral
and speech impairment and is often heralded by wor- blood flow by hyperventilation is used to control acute
sening headache and increasing blood pressure. 82 Cer- increase of intracranial pressure such as epidural haema-
ebral arterial spasm, as revealed by angiography, is a toma. Voldby et al. 34 studied cerebral vasomotor reactivity
major cause of delayed cerebral ischaemia. 23 Using pos- to hypocapnia in 43 patients between the 3rd and 13th
itron emission tomography, Carpenter et al. 33 measured day after rupture of an intracranial aneurysm and re-
the regional CMRO2, oxygen extraction fraction and ported that the cerebrovascular response to hyperventi-
CBF, and concluded that the initial aneurysm rupture lation was generally preserved. Clinical grading of SAH
produced a primary reduction in CMRO2 and that sub- (Hunt and Hess classification) correlates with the disturb-
sequent vasospasm caused ischaemia. ance of carbon dioxide reactivity, autoregulation and in-
Delayed cerebral ischaemia is the major cause of death traeranial pressure (Table II). In animals, Artru et al. 44
and disability in patients with SAH. The treatment of reported that carbon dioxide responsiveness was abol-
cerebral vasospasm may be considered in the following ished during profound hypotension induced with trimet-
Abe" HYPOTENSION AND SAH 977
TABLE II ICP and vascular responsiveness after subarachnoid haemorrhage
ICP CO 2 response Autoregulation
Grade mmHg) ACBF/ A PCO 2 ACBF/ A%MABP
II 01 + 3 16.1 5:0.67 -0.042 -I- 0.194
III 81 + 6 20.1 + 0.5 -0.230 -1- 0.514
IV-V 29 -t- 6 0.61 5:0.42 -0.Mzl 5:0.219
Data are mean + SD. Units for CO 2 response are ml- 001 g-Z. min-i change in CBF' mmHg -I change in CO .2
Autoregulation is expressed as ml. 001 g-i. min-~ change in CBF' % change in MAP (a value of 0.000 would
be perfect autoregulation, and a more negative number indicates progresssive autoregulatory impairment.
From Voldby ,B Enevoldsen EM, Jensen FT. Cerebrovascular reactivity in patients with ruptured intmcranial
aneurysm. J Neurosurg 1985; :26 59, and Voldby ,B Enevoldsen EM.Intracranial pressure changes following
aneurysm rupture. Part I: clinical and angiographic correlations, J Neurosurg 1982; :65 186.
And from Todd MM, Warner DS. Neuroanesthesia: a critical review. In: Rogers MC, Tinker JH, Covino BG,
Longnecker DE (Eds.). Principles and Practice of Anesthesiology. Mosby Year Book 1992; .3361
aphan or sodium nitroprusside. We evaluated carbon di- was a close correlation between the degree of cerebral
oxide reactivity during deliberate hypotension induced by vasospasm and the impairment of cerebral autoregula-
prostaglandin El (PGEI), nitroglycerin (TNG), nicardi- tion, and patients with slight vasospasm and normal rest-
pine in patients during cerebral aneurysm surgery. 74-54 ing cerebral blood flow pattern frequently showed focal
Nitroglycerin- or nicardipine-induced hypotension did not changes during induced hypotension. Diffuse severe va-
change carbon dioxide reactivity during hypotension in sospasm was accompanied by global impairment of au-
our studies. 74-64 toregulation. There was a correlation between the pres-
ence of cerebral vasospasm and impaired autoregulation
Autoregulation and between the degree, extension of vasospasm and the
Autoregulation protects the brain against ischaemia severity of autoregulatory impairment.
caused by decreased blood pressure. The exact mech-
anism of autoregulation is unknown but cerebral resist- Cerebral blood flow
ance vessels dilate in response to a decrease in arterial Several methods are available to measure CBF including
blood pressure or an increase in intracranial pressure. 84,2 noneX331 inhalation, 55 J33Xenon clearance, 75-65 xenon
Cerebral autoregulation is a vulnerable mechanism: im- computed tomographic blood flow mapping, 85 positron
pairment of autoregulation has been found in patients emission tomography, 95 and the hydrogen clearance tech-
with SAH, ~5-94,3 and brain tumour. 93 Severe head injury nique. z6-06 3~iihsI and Pickard et al. 26 reported that, after
is accompanied by marked disturbances of autoregula- SAH, regional CBF was reduced by 52 and 50%, de-
tion. ~5 Loss of autoregulation often correlates with pending on the impairment of consciousness. Values for
changes in cerebral blood flow in the resting condition regional CBF below 20 but higher 21 ml. I00 g-i. min-l
with either hypo- or hyperperfusion, 2s In intracranial were associated with clinical neurological deficits that
tumours, autoregulation is impaired in the diseased area were reversible. The values for regional CBF of 21
and its surroundings. 35 After SAH, cerebral blood flow ml. 001 g-t. min-i or less were associated with clinical
may be reduced in response to small decreases in blood deficits that were not reversible when the vasospasm re-
pressure in patients with cerebral vasospasm. In the first solved. Bell et al. 3~ studied ischaemic cerebral oedema
week after SAH, a 10-20% reduction of mean arterial and regional cerebral blood flow in 14 baboons and re-
blood pressure using trimetaphan or sodium nitroprusside ported that the threshold of ischaemia is 40.5% of normal
decreased CBF in patients with angiographic cerebral ar- cerebral blood flow in cortex and 34.4% of normal flow
terial vasospasm, ~r Using the intraarterial noneX331 in- in subcortical white matter. They concluded that reversal
jection method, Voldby et al. 34 studied the effects of hyp- of the neurological deficit and prevention of ischaemic
otension on CMRO2, AVDO2, cerebral spinal fluid oedema formation can be expected if cerebral blood flow
lactate and intraventricular pressure in 34 patients within can be restored to above the 40% threshold within 30
first 31 days of SAH. Mean arterial blood pressure was minutes. Their results suggest the risk of brain ischaemia
reduced between 01 and 20% for five minutes by/v tri- during induced hypotension. In our studies, prostaglandin
metaphan or sodium nitroprusside. The severity of an- El (PGE0 did not change LCBF after the induction of
giographic cerebral vasospasm was measured by angi- hypotension. 64-54 Trimetaphan decreased LCBF at 30
ography immediately after the CBF study and there minutes after the start of agent but increased to the pre-
780 CANADIAN JOURNAL OF ANAESTHESIA
treatment level after its discontinuation, 46 whereas nitro- and cerebral vasospasm may disrupt cerebra autoreg-
glycerin increased LCBF at 30 rain after the start and ulation, especially in patients with low classification grade.
decreased to the pretreatment level after its discontinua- The safety of systemic hypotension during cerebral aneu-
tion. 64 rysm surgery depends on preservation of adequate CBE
Cerebral metabolic rate (CMR) is the rate at which Hitchcock et al. studied the outcome in 211 patients op-
the brain used or produced metabolic substrates or by- erated upon for clipping of intracranial aneurysms and
products, oxygen (CMRO2), glucose (CMR-GIu), or lac- concluded that the incidence of postoperative neurological
tate (CMR-Lact). Cerebral metabolic rate plays a major deficits was higher in those patients subjected to intraop-
role in the control of cerebral blood flow and si altered erative hypotension below 60 mmHg mean arterial blood
by anaesthetics. pressure and the duration of hypotension. 17 The margin
of safety is reduced during induced hypotension and
Cerebral arterial blood flow velocity therefore the technique should be used only when it may
The normal value of mean middle cerebral artery (MCA) benefit the patient and only by those trained and ex-
blood flow velocity varies from 53 to 90 cm. see -l and perienced in its use. 5 The competency of cerebral au-
an average value is about 60 cm. sec -I during awake toregulation and CBF in aneurysm patients during hyp-
and resting states. 56 Elevation of mean MCA velocities otensive anaesthesia is variable. Considerable effort has
> 021 cm. see -l has been widely used as the criteria for been directed to determine the ideal drug for induced
vasospasm. 76.66 The degree of MCA velocity elevation has hypotension. The three drugs in the most common use
been correlated with the clinical symptom caused by de- are TNG, SNP and isoflurane, but there are no pro-
layed ischaemia. 66 A rapid increase of velocity may pre- spective studies demonstrating an improved neurologic
dict neurological deterioration, but high velocities are outcome with any agents. Lam et al. performed a retro-
often unaccompanied by neurological symptoms. 86,66 spective study in 58 patients receiving a combination of
Davis et al. compared serial arterial velocities and neu- halothane (0.5-1%), fentanyl and SNP, and in 501 pa-
rological deficits in 34 patients after SAH, and reported tients with isoflurane-induced hypotension. Outcome was
that eight of 61 patients without delayed ischaemia evaluated as - good: complete recovery except for minor
had evidence of vasospasm (MCA velocity >120 cranial nerve dysfunction; satisfactory: major focal neu-
cm. sec-~). 96 They concluded that concordant vasospasm rological deficit; poor: vegetative state or death. They con-
and hypoperfusion were most often present in patients cluded that there were no differences in outcome between
with delayed ischaemia and lateralizing neurological def- the hypotensive methods. 27
icits. Marked reduction in arterial pressure diminishes bleed-
ing and on occasion allows the neurosurgeon to regain
Induced hypotension during cerebral aneurysm surgery control of an irreversible situation but the neurological
Induced hypotension has been used during cerebral aneu- and systemic effects of severe hypotension coupled with
rysm surgery to reduce the risk of intraoperative aneur- extreme blood loss should be borne in mind, and normo-
ysmal rupture. Intraoperative rupture of a cerebral aneu- tension, normovolaemia, administration of cerebral pro-
rysm dramatically interrupts a microsurgical procedure tective agents, and appropriate temporary clipping can
and jeopardizes the outcome for the patient. However, be utilized to minimize the risk of cerebral ischaemia. 37
it is controversial whether induced hypotension si useful Ausman et al. 47 concluded that it may be unreasonable
in the prevention and management of intraoperative to make the whole brain hypotensive when only the vessel
aneurysmal rupture. Giannotta et al. performed a retro- with the aneurysm needs to be controlled and they rec-
spective analysis in 276 consecutive surgical procedures ommended the use of temporary vascular clips. Although
for 713 intracranial aneurysms to determine the factors no clinical comparisons between induced hypotension
that governed the outcome from intraoperative rupture and temporary vascular clipping have been done, there
of aneurysms. There were 61 intraoperative aneurysmal are some advantages to temporary vascular clipping. In
ruptures in 801 operations without induced hypotension patients with impaired cerebral autoregulation and de-
and 20 ruptures in 861 operations with hypotension, but creased CBF after SAH, temporary vascular clipping may
in cases of induced hypotension, 11 of the 20 patients be safer than induced hypotension, because it decreases
suffered from permanent deficits or died. However, all flow only to that portion of the brain supplied by the
61 patients of intraoperative ruptures without induced temporarily occluded vessels and maintains collateral
hypotension made a good recovery. They concluded that flow, rather than decreasing CBF to the entire brain
induced hypotension may not be necessary in the man- through induced hypotension.
agement of intraoperative rupture of aneurysm.7~ The Extreme intraoperative hypertension is one of the
major argument against induced hypotension is that SAH major problems during cerebral aneurysm surgery. The
Abe: HYPOTENSION AND SAH 187
treatment of hypertension in association with SAH is nitrate, sodium thiosulphate, or hydroxycobalamin. The
complicated in cases of cerebral vasospasm that may ex- combination of SNP with captopril reduces the dose re-
acerbate fluctuations in CBF. It has been reported that quirement of SNP. 18 Sodium nitroprusside markedly in-
antihypertensive therapy should be withheld except when creases the intracranial pressure in patients with low in-
elevations in blood pressure are extreme because the clear tracranial compliance 38-28 and the effect is even greater
benefits have not been shown from reducing CBE 57 than nitroglycerin, u Cerebral vasodilatation induced by
SNP is unlikely to affect regional cerebral blood flow
evisnetopyH sgurd which remains unchanged during the hypotension and
gross cerebral metabolic disturbance have not been ob-
Prostaglandin ~E served. s8 Sodium nitroprusside may induce coagulation
The prostaglandins are a large family of naturally oc- disturbances and SNP-induced coagulation abnormalities
curring substances with a variety of biological actions. can induce increased bleeding caused by vasodilatation. 68
Prostaglandin El (PGEt) reduces blood pressure by re- Cerebral perfusion is better maintained during drug-
laxing vascular smooth muscle, mainly by dilatation of induced hypotension; of the drugs commonly used, per-
resistance vessels, but in large doses may exert a pre- fusion is maintained best with SNP. s Cerebral blood flow
dominant vasodilator action on the systemic arterial cir- is maintained during SNP-induced hypotension. 78 How-
culation so that it induces systemic hypotension. 77,67 In ever, high organ blood flow alone may not guarantee
our study, PGEI (initial dose: 1.0 ~g. kg -~- min -I ) was adequate tissue oxygenation and this may be particularly
infused continuously to induced systemic hypotension, relevant with SNP because it has no effect on CMRO2 88.
and PGEt did not change LCBF and carbon dioxide
reactivity during surgery, but the hypotensive effects of Adenosine
PGE~ persisted after its discontinuation. 64,54 Goto et al. Adenosine is an endogenous vasodilatator and si involved
also reported prolongation of the hypotensive effect dur- in several vascular beds. It is normally salvaged from
ing general anaesthesia, although the blood concentration the tissue and rephosphorylated by ATP-dependent kinase
of PGE~ decreased to preadministration levels about ten ~9-98.snoitcaer It has been used to induce hypotension in
minutes after the end of infusion. s7 Although PGEI in- cerebral aneurysm surgery due to its rapid onset and
hibits platelet aggregation 97 Carlson reported that inhi- stable hypotensive action without rebound hypertension,
bition did not occur at clinically used doses of PGE~. ~s and its favourable cardiovascular effects 29,19 with only
minor decreases in whole body oxygen consumption, 9s
Sodium nitroprusside The effects of this agent are rapidly and spontaneously
Sodium nitroprusside (SNP) has been used to induce reversed when its administration is discontinued and it
hypotension during cerebral surgery because it has a has no haematological or biochemical toxicity. 98 Lager-
rapid onset and a short half-life. Its onset of action is kranser et al. studied the effects of adenosine-induced
within 30 sec, and peak hypotensive effect occurs within hypotension on CBE CMRO2 and cerebral lactate pro-
two minutes and hypotensive effect disappears within duction in ten patients undergoing cerebral aneurysm
three minutes after its discontinuation. Sodium nitroprus- surgery and reported that adenosine-induced hypotension
side primarily dilates resistance vessels, and the haemo- at MAP between 40-50 mmHg (5.3-6.7 kPa) did not
dynamic response to its administration results from a cause any adverse effects on cerebral circulation or oxy-
combination of venous pooling and reduced arterial im- genation. 39 Z'dll et al. 49 reported that adenosine-induced
pedance. Sodium nitroprusside must be administered as hypotension during cerebral aneurysm surgery inhibits
a continuous infusion. The initial dose is 0.5-1.5 renin release and induces profound decreases in renal
~tg. kg-J (cid:12)9 min-~ and higher rates are necessary to induce blood flow and glomerular fdtration rate caused predom-
hypotension during surgery. The adverse effects of SNP inantly by afferent glomerular arterilar vasoconstriction.
include cyanide and thiocynate toxicity, rebound hyper- When the adenosine infusion was discontinued, glomer-
tension, intracranial hypertension and blood coagulation ular fdtration rate returned to baseline levels. These re-
abnormalities. The principal metabolite of nitroprusside, suits suggest that its use should be limited to brief periods
cyanide, is converted to thiocyanate in the liver and may of hypotension, and it should not be used in patients
accumulate in patients with liver disease. Accumulation with impaired renal function.
of cyanide can occur if SNP is infused at rates greater
than 2 ~tg. kg -j (cid:12)9 rain -I . The risk of thiocynate toxicity Nitroglycerin
increases when SNP is infused for more than 24 hr, es- Organic nitrates are polyesters of nitric acid, whereas or-
pecially if renal function is impaired. Toxic effects may ganic nitrites are esters of nitrous acids. Nitrate esters
be prevented or reversed by the administration of sodium are characterized by a sequence of carbon-oxygen-
287 CANADIAN JOURNAL OF ANAESTHESIA
nitrogen. On the other hand, nitro compounds possess
Vascular smooth muscle cell
carbon-nitrogen bonds. Organic nitrates, nitrites and sev-
eral other compounds that are capable of conversion to f Intrace,fu,ar
nitric oxide have been termed nitro-vasodilators. Nitro-
glycerin (TNG) dilates both veins and arteries directly,
and has little effect on the smaller resistance vessels of ONeF-~NC( ~i ON ~ ~nN( t r C1 ~ GMP
the body. Nitroglycerin's relaxation of vascular smooth
HS-'R 'R-SS:R / PMGe ~ r
muscles stems from the intracellular reaction of organic (alldu=~ (Ow~zKI) | ESANIK v.~ ESANIK
,ONO-IF
nitrates with a sulfydryl moiety on the nitrate receptor
~al~,rII )amrlia nietorP ~ atalOt=l.p
to form inorganic nitrite. Nitrite is then oxidized to form
n~a~ct-p "-"'~ ~
nitric oxide. Nitric oxide in combination with tissue thiols nla~lethgiL ~ I..J~ nial~
Ca"
forms an activator of guanylate cyclase, the enzyme that
catalyzes the formation of cyclic guanylic acid (cGMP)
(Figure .)3 The increase in cGMP with guanylate cyclase
ERUGIF 3 citamehcS margaid of ralullec msinahcem of noitca of
activator si associated with relaxation of vascular smooth
negortin gniniatnoc-edixo srotalidosav .)srotalidosavortin( ehT
muscle. Nitric oxide si thought to be the active inter-
noisrevnoc of enisonaug etahpsohpirt )PTG( si dezylatac yb etalynaug
mediator for the action of this broad class of agents. 69-59
.esalcyc cirtiN edixo )ON( devired morf eht srotalidosavortin setavitca
Perioperatively, intravenous nitroglycerin infusion may eht elbulos emyzneosi mrof of etalynaug esalcyc dna stluser ni
be used to reduce blood pressure during cerebral aneu- desaercni cilcyc cilynaug dica )PMGc( sisehtnys dna cilcyc PMG
tnedneped nietorp esanik .noitavitca esehT stneve tluser ni eht
rysm surgery. Cottrell studied the changes in intracranial
noitalyrohpsohped of nisoym thgil niahc dna .noitaxaler morF Ignarro
pressure in hyperventilated patients undergoing craniot-
L ,J Lippton H, Edwards JC, et at J locamrahP pxE rehT ;1891 :812
omy and reported that intracranial pressure increased ,937 dna Murad E cilcyC enisonaug etahpsohponom sa a rotaidem of
from 14.2 to 30.8 mmHg and cerebral perfusion pressure .noitalidosav J nilC tsevnI ;6891 :87 .)3
decreased from 90.2 to 38.2 mmHg. 38 Low intracranial
compliance contraindicates the use of TNG prior to dural
opening. Langerkranser 79 reported that TNG may cause metaphan is rarely used because of the high incidence
increased intracranial pressure, especially in patients with of adverse effects such as bowel and bladder atony and
intracranial hypertension, by its venodilatating effects on the rapid development of tachyphylaxis.
the cerebral circulation and concluded that, during neu-
rosurgical operations, the administration of TNG should, Calcium antagonists
if possible, be restricted to the period when the dura is The use of calcium channel blockers has enabled marked
open, and the lungs should be moderately hyperventi- progress to be made in studies concerning the role of
lated. Maktabi et al. 89 studied the effects of SNP-, TNG- extracellular Ca ++ influx in cardiac and smooth muscle
and isoflurane-induced hypotensive anaesthesia on the contraction. Calcium channel blockers, structurally re-
cardiovascular system and intrapulmonary shunting in 30 lated to nifedipine, are beneficial in the treatment of hy-
patients and reported that cardiac index was decreased pertension, myocardial ischaemia, and cerebral and cor-
more by TNG and isoflurane than with SNP at a mean onary vasospasm during anaesthesia. ~1 The major
arterial blood pressure of 40 mmHg. antihypertensive mechanism of calcium antagonists is by
decreasing systemic vascular resistance, modified by the
~imetaphan counter-regulatory responses of the baroreflexes and the
Trimetaphan (TMP) acts mainly by sympathetic gangli- renin-angiotensin-aldosterone system. ~1 However, the
onic blockade as well as by histamine release. 671~1,99 A dis- calcium channel blockers, verapamil ~1 and diltiazem ~~
tinct advantage of TMP is that automatic reflexes are may produce severe negative chronotropic and dromo-
blocked. Knight et al. demonstrated that norepinephrine, tropic effects when used to induce systemic hypotension.
epinephrine, plasma renin activity, and angiotensin II did Recently, it has been shown that calcium channel blockers
not increase as much after TMP as after SNP. lo~ Using also affect the cerebral circulation. Nicardipine, 801,701 ni-
a thermal gradient blood flow meter, we measured local modipine, 901 7011imaparev and diltiazem "~ increased cer-
cerebral blood flow in 91 patients undergoing cerebral ebral blood flow in animals. Nicardipine is a water-
aneurysm clipping during TMP-induced hypotension and soluble, photoresistant di-hydropyridine calcium channel
found that local cerebral blood flow was reduced with blocker that causes potent systemic and coronary vaso-
.~IMT 36 Turner et al. reported that TMP has little dilator dilatation but does not result in negative inotropic, chro-
action on the cerebral vessels, as indicated by the lack notropic, or dromotropic effects. 11 It has been reported
of increase in intracranial pressure with this drug. 201 Tri- that nicardipine increased cerebral blood flow in humans
Abe: HYPOTENSION AND SAH 387
and animals. ~1 In our study, nicardipine did not with little effect on pulmonary gas exchange or cardiac
change LCBF or carbon dioxide reactivity, but LCBF output, m,m Newman et al. studied the effect of
was improved in patients with good presurgical neuro- isoflurane-induced hypotension on CBF and CMRO2 in
logical status than in those with poor neurological status. 21 patients undergoing cerebral aneurysm surgery and
The hypotensive effect of nicardipine persisted after its concluded that, with regard to global cerebral oxy-
discontinuation which is similar to PGE~ 74 The elimi- genation, isoflurane was a safe agent with which to induce
nation half-life of nicardipine increased to four to eight hypotension. 88 Using thermal diffusion probe, Roth et
hours when a continuous intravenous infusion was ad- a/. 421 measured cerebral cortical blood flow and CMRO2
ministered. 2H Anaesthesia and operation may interfere in patients undergoing cerebral aneurysm surgery and
with drug disposition, and lead to a decrease in systemic concluded that CBF and oxygen delivery were main-
clearance and an increase in plasma concentration. 311 tained during isoflurane-induced hypotension during
Consequently, the continuous administration of nicardi- fentanyl-nitrous oxide anaesthesia. Haraldsted et al. 521
pine to induce hypotension during anaesthesia may result studying the cerebral arteriovenous 02 difference during
in cumulative effects that persist after discontinuation of in 20 patients undergoing cerebral aneurysm surgery, con-
the infusion. It has been reported that the calcium an- cluded that cerebral blood flow and oxygen demand/
tagonists dilate the cerebral resistance vessels and increase supply ratios were maintained favourably during induc-
cerebral blood flow. 411 tion of hypotension with isoflurane at concentrations
Diltiazem is a benzothiazepine derivative calcium an- <2.5 MAC. Isoflurane causes an increase in intracranial
tagonist which acts by interfering with calcium-mediated pressure, 621 plasma epinephrine is decreased but plasma
events in excitation-contraction coupling in cardiac and epinephrine and norepinephrine concentrations and
smooth muscle. The effectiveness of diltiazem in patients plasma renin activity increased during induced hypoten-
with mild to moderate hypertension has been proved in sion in halothane-SNP combined group. It was concluded
double-blind comparison with placebo. 6lj,SH Also, dilti- that isoflurane-induced hypotension with isoflurane
azem was effective when given intravenously to patients anaesthesia, unlike SNP-induced hypotension with halo-
with hypertensive emergencies 711 and/or with postopera- thane anaesthesia, attenuated the stress response. 72~ The
tive hypertension. 811 Intravenous diltiazem has been used role of the endothelium in the vascular response to volatile
to prevent ischaemia in patients with coronary artery dis- anaesthetics remains controversial. Several studies suggest
ease during non-cardiac surgery. ,9 There is some infor- that the volatile anaesthetics may induce endothelium-
mation about the cerebral vascular effects of diltiazem dependent relaxation in isolated vascular rings, 921,82j
which appears to block receptors and potential dependent Stone et al. studied the endothelium-dependent vascular
calcium channels without blocking stretch-induced cal- effects of isoflurane using isolated ring preparations of
cium influx. 021 It has been reported that diltiazem pre- rat thoracic aorta and reported that isoflurane causes va-
vents or at least minimizes Ca ++ entry into the vascular soconstriction through inhibition of basal EDRF produc-
muscle and endothelial cells in the cerebral arteries tion or stimulation of the release of an endothelium-
through potential-sensitive and receptor-operated mech- derived vasoconstriction factor at low concentrations and
anisms, and that this effect has some selectivity for the that at higher concentrations a direct vasodilating effect
cerebral arteries. 121 of anaesthetic predominates. 921 However, the role of the
Verapamil is a less potent vasodilator than nicardipine. endothelium in the vascular response to volatile anaes-
Prompt reduction of blood pressure can be achieved after thetics remains uncertain.
the intravenous administration of verapamil. The cur-
rently recommended dosage is 5 to 01 mg, given as an Other vasodilators
/v bolus over two minutes. Intravenous administration
of verapamil causes a decrease in arterial blood pressure HYDRALAZ1NE
due to a decrease in vascular resistance, but the reflex Hydralazine causes direct relaxation of arteriolar smooth
tachycardia is blunted by the direct negative chronotropic muscle and most of its effects are confined to the car-
effect of verapamil. 311 diovascular system. The decrease in blood pressure is as-
sociated with a decrease in vascular resistance in the cor-
lsoflurane onary, cerebral and renal circulations. Hydralazine is well
The volatile anaesthetic, isoflurane, has been used ex- absorbed through the gastrointestinal tract and the half-
tensively to induce hypotension during cerebral aneurysm life is one hour. Hydralazine is administered in doses of
surgery because of its rapid onset of action, easy con- 20 to 40 mg/v when there is an urgent need to decrease
trollability, and rapid reversal of the cardiovascular effects blood pressure, but the response is very unpredictable
on discontinuation. It causes peripheral vasodilatation and prolonged hypotension is not unusual even with doses
784 CANADIAN JOURNAL OF ANAESTHESIA
TABLE Ill Parenteral medications used ni the treatment of evisnetrepyh seicnegreme
Duration
Drug Administration* tesnO of action Dosage Adverse effects and comments
muidoS v/ infusion Immediate 2-3 nim 0.5-10~tg (cid:12)9 kg -I (cid:12)9 nim - Hypotension, nausea, vomiting, apprehension. Risk
edissurportin (initial dose, 52.0 of thiocyanate and cyanide toxicity si increased ni
"gt~ kg -I- nim -t rof renal and hepatic ,ycneiciffusni ;ylevitcepser slevel
eclampsia and renal dluohs be monitored. Must be shielded from light.
)ycneiciffusni
edixozaiD v/ bolus 5-1 rnin 6-12 hr 50-100 mg every 5-10 ,noisnetopyH tachycardia, nausea, vomiting, fluid
min, up to 006 mg ,noisneter .aimecylgrepyh May etabrecaxe
myocardial ,aimehcsi heart failure, or aortic
v/ noisufni 10-30 "gm nim -l .noitcessid May require concomitant esu of a -31
.tsinogatna
lolatebaL v/ bolus 5-10 nim 3-6 hr 20-80 mg every 5-10 ,noisnetopyH heart block, heart failure,
min, up to 003 gm ,msapsohcnorb nausea, vomiting, scalp ,gnilgnit
paradoxical pressor .esnopser May not be evitceffe
in patients gniviecer -te or .stsinogatna-31
v/ noisufni 0.52-2 mg' rain -j
nirecylgortiN v/ noisufni 1-2 nim 3-5 min 5-100 ~.g' min -t ,ehcadaeH nausea, vomiting. Tolerance yam poleved
with prolonged use.
nahpatemirT v/ noisufni 1-5 nim 01 nim 0.5-5 mg" nim -I ,noisnetopyH urinary retention, ileus, respiratory
arrest, mydriasis, ,aigelpolcyc dry mouth. More
evitceffe if patient's head is .detavele
enizalardyH (for v/ bolus 02-01 rain 3-6 hr 5-10 mg every 02 nim (if ,noisnetopyH fetal distress, tachycardia, headache,
treatment of no tceffe after 02 ,gm try ,aesuan vomiting, local thrombo phlebitis; noisufni
)aispmalce another agent) site should be changed after 21 .rh
~enipidraciN v/ noisufni 1-5 rain 3-6 hr 5 "gm hr -I, increased by ,noisnetopyH headache, tachycardia, nausea,
1-2.5 mg- hr -l every 51 .gnitimov
min, up to 51 mg' hr -I
v/* denotes .suonevartni
toN"1 yet approved by eht Food and Drug Administration for this .esu
From Calhoun LA, Oparil S. Treatment of evisnetrepyh crisis. weN Engl J Med ;0991 .9711:322
as low as 10 mg. James et al. studied the effect of LOLATEBAL
hydralazine-induced hypotension during enflurane anaes- Labetalol acts as a competitive antagonist at both eq-
thesia in patients during neurosurgical operations, and and 13radrenergic receptors. The actions on both eq and
reported that hydralazine is a simple, smooth, predictable, j31 adrenergic receptors induces a decrease in blood pres-
nontoxic technique to induce hypotension during neu- sure in patients with hypertension. Orlowski et al. ad-
rovascular operations. 031 ministered labetalol to 15 postoperative neurosurgical pa-
tients who had undergone neurovascular surgery. The
EDIXOZAID patients had been treated initially with SNP to maintain
Initially, diazoxide was developed as an oral antihyper- reasonable arterial blood pressure, but because of ex-
tensive drug, but it induced unacceptable side effects (hy- cessive SNP dose requirements, intravenous labetalol was
perglycaemia, hypertrichosis). It was given parenterally administered. Mean intracranial pressure decreased from
for the treatment of hypertensive emergencies, but sodium 11.3 + 6.1 mmHg with SNP to 8.6 + 3.1 mmHg after
nitroprusside has replaced diazoxide as the drug of choice conversion to labetalol. 231
for hypertensive cases. Although the plasma half-life of
diazoxide is 20 to 60 hr, the duration of the hypotensive LOLOMSE
response is variable and can be as short as four hours Esmolol is a selective 131 antagonist with a very short
or as long as 20 hr. The main indication for diazoxide duration of action and has a half-life of about eight min-
is the treatment of hypertensive emergencies. However, utes. It has been reported that esmolol and labetalol were
excessive hypotension may induce cardiac or cerebral useful in controlling systolic blood pressure in emergen-
damage. The most common side effects caused by diaz- cies and in the recovery room in patients undergoing in-
oxide are salt and water retention and hyperglycaemia. 131 tracranial surgery 331 (Table III).